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012.03.0Abstract Aims: A non-optimal resynchronization lead (RL) position is a possible cause of poor
CRT response. The study aims to test the value of real-time-three-dimensional-echocardiography
(RT3DE) for individual assessment of LV dyssynchrony and prospective evaluation of CRT
response after RL implantation at the pre-determined segment of maximal delay (SMMD) whatever
the method of CRT used.
Methods: Seventeen HF patients were prospectively included in the study. RT3DE data were
obtained before and after 1, 3, 6 months of CRT. Time/volume curves and parametric imaging were
applied for pre-implant identiﬁcation of SMMD and for individual assessment of CRT response.
Delta-time delay (delta-t) and selective parameters between tmsv of the latest and earliest activated
segments were calculated.
Results: All patients received CRT according to accessibility of the SMMD. We used bifocal right
ventricular pacing (BFRVP) in 5 patients with septal SMMD; biventricular pacing (BVP) in 12
patients with LV SMMD. The RL was successfully implanted at the SMMD or nearest segment
in 14 (82.4%) initial responders (5 BFRVP, 9 BVP). Twelve of them were still responders after
6 months. CRT response was comparable in BFRVP and BIVP. A moderate correlation was found
between % change of EF and that of SDI (r= .406), delta-t (.497). Baseline delta-t showed a
stronger correlation with % change of EF (r= .718**, P= 0.009) than that of SDI
(r= .509, P= 0.091).2356753 (work), mobile: +20
m (D.A. Fouad).
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156 D.A. Fouad, R.M.S. EldeenConclusion: The use of RT3DE for individual assessment of LV mechanical dyssynchrony and for
optimal RL positioning at the pre-identiﬁed SMMD can provide more optimum CRT regardless
the method of CRT.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Although CRT was proved beneﬁcial for patients with symp-
tomatic HF associated with LV asynchrony,1–10 about 1/3 of
patients are inadequate responders.11–13 Thus, accurate deter-
mination of mechanical dyssynchrony has become increasingly
important. In this respective, positioning of the LV lead at the
site of latest mechanical activation may result in maximum
CRT beneﬁt.14 This optimal lead position has been proposed
to provide the greatest resynchronization and hemodynamic
beneﬁt.14–20 Meanwhile, BFRVP was reported to be success-
fully used to achieve cardiac resynchronization and improve
clinical manifestations in patients with severe HF.21,22 This
was found on acute and short-term23–26 as well as long-term
follow-up.27,28 Accordingly, we thought that using BFRVP
can induce more optimum CRT if the SMMD was septal.
Meanwhile, RT3DE provides a powerful tool for qualita-
tive and quantitative assessments of the LV. The clinical use
of RT3DE has been established and validated against angiog-
raphy, radionuclide angiography, and MRI for assessment of
LV volumes and functions.29 Regional correspondence of the
maximum contraction is used as an indicator for dyssynchro-
ny. A systolic dyssynchrony index derived from the regional
volumes has been proposed and preliminarily validated as a
method of quantifying global LV mechanical delay.30 In addi-
tion, whether or not a patient beneﬁts from CRT can often be
determined by comparing the regional volume curves derived
from pre- and post-CRT RT3DE datasets.31
2. Aims
The purpose of this study was to test the value of RT3DE for
individual assessment of LV mechanical dyssynchrony, deter-
mination of SMMD, and for prospective evaluation of CRT
response when the RL is positioned at the pre-determined
SMMD whether the method of CRT used was BIVP or
BFRVP.
3. Patients and methods
3.1. Patients
Seventeen HF patients scheduled for CRT in our cardiology
department were prospectively included in the study starting
from 2008 till 2010. All patients fulﬁlled the following inclu-
sion criteria: advanced HF (NYHA class III or IV) despite
optimal medical treatment, EF 6 35% deﬁned by modiﬁed
Simpson´s method, QRSP 120 ms in LBBB pattern, and
SDIP 5 by RT3D. Patients were excluded if they were
618 years, had valvular disease, reduced life expectancy, ische-
mic episode during last 6 months, other pacemaker indication,
and unsuitable equisetic window. Written consents were ob-
tained from patients before participation in the study. Theinvestigational protocol was approved by the Ethical
Committee.
3.2. Methods
Patients were assessed before CRT regarding examination of
12-lead surface ECG, clinical evaluation of NYHA functional
class score and echocardiographic evaluation. Using Philips IE
33 device, preliminary 2-D echocardiography was performed
to obtain LV end diastolic and systolic volumes, and EF%
(LVEDV, LVESV, EF%) by modiﬁed Simpson’s method. Full
volume RT3DE data were then obtained from apical window
to assess the same parameters in addition to deﬁnition of the
SMMD and LV dyssynchrony parameters. Evaluation was re-
peated after 1, 3 and 6 months of CRT.
3.2.1. RT3DE protocol
a. Data acquisition and analysis
Echocardiographic evaluation was done using Philips iE 33
devices, software level 2.1.0.507 equipped with scan-head s5-1.
Pure wave crystal x3-1 4D matrix array transducer was used to
obtain full-volume 3D data. These data were obtained from
the apical window while the patient is in left lateral position.
A full volume scan was acquired in harmonic mode from 3
R wave triggered volumes during an end-expiratory breath-
hold.
Analysis of RT3DE datasets were performed on a QLAB
workstation using Philips version 6.0, 3D-Advanced quantiﬁ-
cation software. LV quantiﬁcation was performed to generate
a LV 3-D model subdivided into 17 different colors so that re-
gional and global volume curves were analyzed. LVEDV,
LVESV, and EF% were generated automatically by the soft-
ware (Fig. 1a). LV segmentation was performed according to
a 17-segment model32 where tmsv was calculated in the 16 seg-
ments (excluding the apex) to obtain time/volume curve. The
QLAB automatically calculates the SDI deﬁned as the stan-
dard deviation of tmsv of the 16 segments corrected for R–R
duration and displayed as a percentage (tmsv-16 SD %)
(Fig. 1b). Patients were only included if they had SDIP 5.30
Moreover, the QLAB software allows manual selection of
any number of segments.
b. Determination of the latest mechanical activation
This was performed using both time/volume curves and
parametric imaging.
– Time/volume curve. Based on segmental time/volume
curves, the segment (segments) with the latest tmsv was pre-
operatively deﬁned as the SMMD. The segment with the
earliest tmsv (usually opposite to the SMMD) at the 17-seg-
ment model was also deﬁned. Individual measurement of
delta-t, selective tmsv SD (tmsv sel SD), selective tmsv dif-
ference (tmsv sel dif), the % of tmsv sel SD (tmsv sel SD
%), and the % of tmsv sel difference (tmsv sel dif.%)
Figure 1 Obtaining RT3DE data. (a) Post-processing of RT3DE
dataset showing semiautomatic tracing of LV endocardial borders
obtaining LDV, LSV, EF% and time volume curves assessing
synchronicity in the same frame. (b) Automatic calculation of SDI
of the same patient (tmsv-16 SD %); RT3DE SDI is 30.99% in
this patient.
The role of real time three dimensional echocardiography 157between tmsv of these 2 opposite selected segments was then
performed to assess individual mechanical dyssynchrony.
After CRT, determination of the new tmsv point of the
SMMD and its relation to the tmsv of the opposite segment
was done. The same parameters were recalculated to assess
the efﬁcacy and extent of resynchronization. In responders,
the SMMD is resynchronized so that its tmsv becomes ear-
lier and in harmony with other segments including the pre-
viously earlier opposite segment. Fig. 2 shows parametric
imaging and time/volume curve of 2 of our responders.– Parametric imaging. Parametric imaging was applied to
identify areas of latest mechanical activation and to identify
myocardial velocity and excursion at different segments.
The tmsv distribution from all LV segments was displayed
on a static Bull’s eye color map as previously described33,34
(Fig. 2).
3.2.2. Implantation technique
Patients were meant to receive CRT so that the RL would be
positioned at the pre-identiﬁed SMMD or the nearest possible
segment. If more than one segment had the same tmsv, both
segments are considered SMMD.
Twelve of the 17 patients had the SMMD at the free LV
wall. These patients received conventional BIVP. Meanwhile,
we used BFRVP in 5 patients with pre-identiﬁed septal
SMMD.
For BIVP, coronary sinus venogram was obtained using a
balloon catheter, followed by insertion of the LV lead into a
cardiac vein corresponding to the SMMD or nearest segment.
BFRVP patients received dual chamber pacemaker systems.
An active ﬁxation lead was screwed to the interventricular sep-
tum also at or nearest to the SMMD. An atrial lead was con-
nected to the atrial channel of the pacemaker, 2 ventricular
leads (apical and septal) were connected to the ventricular
channel by a Y-shaped lead adaptor. Before discharge, all pa-
tients were programed in the DDD mode with optimal AVD
allowing maximum LV diastolic ﬁlling with separation of E
and A waves of the mitral valve. LV and RV stimulation
was simultaneous with no VV optimization.
3.2.3. Response to CRT
Clinical response was considered if there wasP1 NYHA class
improvement. Reversed remodeling was considered if there
was P15% reduction of ESV.35
3.2.4. Statistical analysis
Data were entered and cleaned in excel 2007 sheet then we used
SPSS software package version 16 for data analysis. Non para-
metric tests were done where descriptive statistics (mean and
SD) were calculated. Mann Whitney test, sign test and spear-
man rank correlation were used. The probability of <0.05
(p-value) was used as cut off point for all signiﬁcant tests.4. Results
The study included 17 HF patients (12 males, 5 females) aged
51.06 ± 19.64 years. Eleven of them had ischemic cardiomy-
opathy, 6 had idiopathic dilated cardiomyopathy. All patients
were in sinus rhythm except for 2 (1 BIVP, 1 BFRVP). Six pa-
tients had mid-anterolateral, 4 mid-inferolateral, 1 basal-anter-
olateral, 1 mid-anterior, 2 mid-anteroseptal, 2 mid-
inferoseptal, 1 basal inferoseptal SMMD.
4.1. Response to CRT among the study population
Fourteen of 17 patients (82.4%) were initial responders after
1 month of CRT. Twelve patients (70.5%) maintained beneﬁ-
cial CRT response after 6 months compared to 5 non-respond-
ers. All baseline characters were comparable in responders and
Figure 2 (a, b) Parametric imaging and time/volume curve before (right panel), and after (left panel) optimum LV lead positioning of a
BIVP patient. (c, d) Parametric imaging and time/volume curve before (right panel), and after (left panel) optimum RV septal positioning
of a BFRVP patient.
Table 1 Baseline clinical and RT3DE indices in responders vs. non-responders of the study population.
Responders (No. 12) Non-responders (No. 5) P value
Age 46.83 ± 20.79 61.20 ± 13.16 NS
Ischemic CM 7/12 4/5 NS
QRS 165.21 ± 36.30 160.0 ± 39.37 NS
NYHA class 3.80 ± 0.447 3.85 ± 0.515 NS
EDV (ml) 282.25 ± 65.51 281.40 ± 62.72 NS
ESV (ml) 213.92 ± 42.05 227.00 ± 30.64 NS
EF (%) 24.28 ± 5.49 18.60 ± 5.99 NS
SDI 11.03 ± 5.15 13.72 ± 4.33 NS
Delta-t 0.171 ± 0.01 0.154 ± 0.02 NS
CM= cardiomyopathy, SDI = systolic dyssynchrony index, EDV, ESV= end diastolic and systolic volumes, Delta-t = delta time delay
between tmsv of SMMD and tmsv of opposite segment.
158 D.A. Fouad, R.M.S. Eldeennon responders (Table 1). However, responders had non-
signiﬁcantly younger age, better EF%, and SDI than the
non-responders. Meanwhile, delta-time was non-signiﬁcantly
higher in responders compared to non-responders.
4.1.1. Positioning of RLs in responders vs. non-responders
Guided by parametric imaging and time/volume curves, the
RL could be implanted at the SMMD or the nearest possible
segment of the same wall in 15 patients (10 LV leads and 5
RV septal leads).ALV leadwas implanted in a lateral tributary of the coronary
sinus (CS) in 9 patients (4 inferolateral, 5 anterolateral). It was
positioned at an anterior tributary in 1 patientwhere the SMMD
was mid anterior. However, lateral SMMDs were technically
non-achievable in 2 patients (one had no suitable CS tributaries
corresponding to the pre-identiﬁed SMMD, the other developed
diaphragmatic stimulation at the SMMD). So, the LV lead was
positioned at a postero-lateral branch remote from the SMMD
in these 2 patients. A septal RV lead was positioned at or nearest
to septal segment proved to be the SMMD in 5 patients.
























Figure 3 LV dyssynchrony parameters in responders and nonre-
sponders. (a) Changes of SDI and (b) changes of delta time.
The role of real time three dimensional echocardiography 159After 1 month of CRT, 14 of the 15 patients with optimum
RL position were initial responders (all the 5 BFRVP, 9 BIVP
patients). At the end of follow-up, 12 of these 14 patients (8
BIVP, 4 BFRVP) were still responders. Thus, 12/15 (80%) of
patients having optimal RL position maintained a beneﬁcial
CRT response at medium term.
Meanwhile, the SMMD could not be achieved in 2 non-
responders, while 3 patients were non-responders despite opti-
mum RL positioning.
4.2. Patients’ follow-up
Five patients (4 BIVP, 1 BFRVP) were non-responders. Two
BIVP non-responders had a non-optimum RL position, while
2 were non-responders despite optimum RL positioning (one
died after 1 month, the other most probably had scar tissue
at the SMMD). Meanwhile, 1 BFRVP patient developed
reduction of LV function on the second follow-up visit despite
near-optimum RL position.
The 12 responders developed signiﬁcant improvement after
CRTwithout sex related signiﬁcance.NYHAscoredecreased from
3.80 ± 0.447 to 1.55 ± 0.52 after 6 months (P< 0.001). This was
associated with reversed LV remodeling; namely signiﬁcant
improvement of ESV (213.92 ± 42.05 ml–163.75 ± 38.41) and
EF% (24.28 ± 5.49–42.44 ± 5.67%) (P< 0.05 for both). Non
responders exhibited no improvement of cardiac function indices
compared to baseline.
SDI decreased signiﬁcantly from 11.03 ± 5.15 to 2.39 ± 1.18
after 6 m of CRT (P< 0.001) in the responders. On the contrary,
SDI was worsened in the non-responders recording higher values
than baseline (13.72 ± 4.33–14.87 ± 5.41; P> 0.05) (Fig. 3a).
Selective dyssynchrony indices exhibited signiﬁcant and compara-
ble reduction to SDI. After 6 m of CRT, tmsv sel SD decreased
from 90.17 ± 32.97 to 5.50 ± 3.28, tmsv sel dif. from
141.00 ± 29.39 to 11.16 ± 6.68, tmsv sel SD % from
20.49 ± 10.42 to 5.50 ± 0.94, tmsv sel dif.% from
36.41 ± 23.53 to, and delta time from 0.171 ± 0.012 to
0.013 ± 0.00 (P< 0.0001 for all) (Fig. 3b). These parameters
were not signiﬁcantly changed in the non-responders.
Meanwhile, responders had a mild to moderate correlation
between the % change of EF% and that of SDI (r= .406),Table 2 Correlation between dyssynchrony indices and % change





Sel. SD r 0.322
P value 0.308
Sel. SD % r 0.462
P value 0.131
Sel. dif. r 0.455
P value 0.138
Sel. dif.% r 0.007
P value 0.983
Delta-t = delta time delay, sel SD = selective tmsv SD, sel dif = selective
% of tmsv sel.
* p< 0.05.
** p > 0.01.delta-t (.497), tmsv sel SD (.650), tmsv sel dif. (.559), tmsv
sel SD % (.538), tmsv sel dif.% (.503). Baseline delta-t
showed a stronger correlation with % change of EF
(r= .718**, P= 0.009) than that of baseline SDI
(r= .509, P= 0.091) automatically obtained from RT3DE
dataset (Table 2).of EF%.





Sel. SD r .650*
P value 0.022
Sel. SD % r 0.538
P value 0.071
Sel. dif. r 0.559
P value 0.059
Sel. dif.% r 0.503
P value 0.095
tmsv difference, sel SD %= the % of tmsv sel SD, sel. dif.% = the
Table 3 Serial clinical and RT3DE changes in responders of BIVP and BFRVP groups.
BIVP (8) BFRVP (4) P value
NYHA
Baseline 3.75 ± 0.46 3.25 ± 0.50 NS
1 m 1.12 ± 0.35** 1.67 ± 0.57** NS
3 m 1.25 ± 0.46** 1.33 ± 0.57** NS
6 m 1.50 ± 0.53** 1.67 ± 0.57** NS
EDV (ml)
Baseline 283.63 ± 66.31 276.50 ± 73.67 NS
1 m 268.12 ± 54.42 254.50 ± 65.50 NS
3 m 272.62 ± 45.33 249.00 ± 46.23 NS
6 m 267.75 ± 30.82 252.00 ± 49.22 NS
ESV (ml)
Baseline 213.50 ± 49.96 214.75 ± 25.64 NS
1 m 174.50 ± 39.12** 163.00 ± 40.14** NS
3 m 165.00 ± 30.93** 158.75 ± 51.98** NS
6 m 167.75 ± 30.82** 170.75 ± 73.53** NS
EF (%)
Baseline 23.89 ± 4.78 25.08 ± 7.47 NS
1 m 38.78 ± 5.48*** 42.75 ± 2.50*** NS
3 m 42.26 ± 5.98*** 45.15 ± 3.39*** NS
6 m 40.50 ± 5.90*** 43.32 ± 2.54*** NS
** Signiﬁcance is related to baseline measurement, p< 0.001.
*** Signiﬁcance is related to baseline measurement, P< 0.0001.
Figure 4 LV dyssynchrony parameters in responders of BIVP vs. BFRVP. (a) Changes of SDI, (b) changes of tmsv selective SD and (c)
changes of delta time.
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At the end of the 6 months´ follow-up period, 8 of the 12 BIVP
patients (66%) maintained beneﬁcial CRT response vs. 4 of the
5 BFRVP patients (80%) (P= 0.582). The mean age of BIVP
responders (5 males, 3 females) was 52.38± 21.45 vs.
45.75± 16.29 of BFRVP responders (3 males, 1 female);
P> 0.05. Responders of both device groups had a comparable
signiﬁcant improvement of NYHA class and reversed remod-
eling parameters (Table 3).
4.3.1. Assessment of LV synchronicity in responders of the 2
groups
Baseline dyssynchrony parameters were non-signiﬁcantly (ex-
cept for delta-t) higher in responders of BIVP compared to
those of BFRVP. During follow-up, these parameters de-
creased signiﬁcantly and comparably in the 2 groups. After
6 months, SDI of BIVP responders decreased from
11.14 ± 3.25 to 2.36 ± 1.13, sel SD from 96.63 ± 30.86 to
6.00 ± 3.62, sel dif from 148.88 ± 24.24 to 10.00 ± 7.07, del-
ta-t from 0.177 ± 0.01 to 0.006 ± 0.0, sel SD % from
24.95 ± 9.96 to 1.33 ± 1.37, sel dif.% from 44.62 ± 25.15 to
2.56 ± 2.45. Meanwhile, SDI of BFRVP responders decreased
from 10.79 ± 6.10 to 2.46 ± 1.46, sel SD from 77.25 ± 37.81
to 4.50 ± 2.64, sel dif from 125.25 ± 36.06 to 9.50 ± 6.45,
delta-t from 0.159 ± 0.00 to 0.014 ± 0.0, sel SD % from
18.69 ± 4.85 to 0.90 ± 0.91, sel dif.% from 30.00 ± 4.05 to
1.48 ± 1.18, P< 0.05 for delta-t, P< 0.0001 for others
(Fig. 4).
5. Discussion
The invasive nature of CRT, its high cost, and high rate (20–
30%) of non-responsiveness,11–13 increasing to 40–50% when
reverse LV remodeling is an end point,1 have made candidate
selection a crucial issue. Optimal lead position was proposed to
provide the greatest resynchronization and hemodynamic ben-
eﬁt.14–20 However, the site of SMMD may vary signiﬁcantly. It
was suggested to be within the lateral wall in 67–89% of pa-
tients, it may be found at different other regions.15,36 The sin-
gle most delayed segment was septal in 12–16% of cases.37
Presently, there has not been any clinical study evaluating
the role of RT3D echocardiography in guiding CRT or its
association with cardiac outcomes.38 To our knowledge, this
small study is the ﬁrst prospective study evaluating the role
of RT3DE to guide optimum RL position in CRT.
We used RT3DE for individual assessment of LV systolic
dyssynchrony and pre-implant identiﬁcation of the SMMD.
Using time/volume curves and parametric imaging, the
SMMD could be identiﬁed preoperatively in all of the 17 pa-
tients of the study. It was lateral in 11 (64.7%), septal in 5
(29.4%), and anterior in 1 patient.
Because reaching the SMMD was the main goal of the pres-
ent study and because BFRVP was a successful method of
CRT with beneﬁcial CRT response21–28; we thought to use a
RV septal lead as the RL in case of septal SMMD. Accord-
ingly; BFRVP (using RV septal lead as RL) was chosen in 5
patients with pre-identiﬁed septal SMMD while BIVP was
used in 12 patients with free LV wall SMMD. RT3DE facili-
tated positioning of the RL at or nearest to the SMMD in
15 (88%) patients (10 BIVP, 5 BFRVP). Twelve of these pa-tients have constituted the responder group of patients after
6 months of CRT. Notably, 100% of responders had an opti-
mum or near-optimum RL position while only 2/15 patients
(13.3%) did not respond to CRT despite optimum lead posi-
tioning. Meanwhile, reaching septal SMMD was easily
achieved in all BFRVP patients while it was more difﬁcult in
lateral SMMD. It was technically impossible in 2/12 of the
BIVP patients. Similar results were reported from other stud-
ies.21–28
Response to CRT was comparable among responders of
both BFRVP and BIVP groups after optimum RL positioning.
Responders of both groups developed comparable and excel-
lent CRT response (Table 3) together with comparable and sig-
niﬁcant reduction of SDI and selective dyssynchrony indices.
So that optimum RL positioning increased the percentage of
CRT response up to 80% (12/15) as well as its extent.
Our results are in agreement with those of many studies14–20
emphasizing, although not prospectively, greater CRT re-
sponse in patients paced at the site of SMMD and an increas-
ingly worse response when the lead was placed more remote
from the site of SMMD. Our results can also explain why can-
didates of CRT where the SMMD are found within the septum
would be non-responders to traditional BVP.
SDI automatically derived from regional volumes of
RT3DE was reported to be an excellent predictor of response
to CRT.30,33,34,39 Kapetenakis et al., 200530 suggested a mean
SDI of 3.5 ± 1.8% for normal subjects, 5.4 ± 0.8%,
10.0 ± 2%, and 15.6 ± 1% for mild, moderate, and severe
systolic dysfunction respectively. Recently, the same authors
identiﬁed a cutoff of 10.4% to predict improvement following
CRT.39 However, some investigators questioned the value of
RT3DE-derived SDI in the evaluation of LV dyssynchro-
ny.31,40 This was attributed to the inability of accurate detec-
tion of end-ejection in low-amplitude regional volume
curves.40 Also, analysis of regional volume curves may not
be sufﬁcient to capture the unique features of CRT responders
or non-responders and to predict the outcome of CRT.31
Alternative indices of dyssynchrony need to be developed to
address this limitation.
RT3DE was the only method we used to assess LV syn-
chronicity before and after CRT. So, only patients with a
SDIP 5 were included in the present study.30 This in addition
to the small sample size could explain our ﬁnding that baseline
SDI was not signiﬁcantly different in responders vs. non-
responders. Attempting to avoid foreshortenings of the auto-
matically obtained SDI, we used time/volume curves to mea-
sure selective dyssynchrony indices between tmsv of the
SMMD and that of the earliest segment before and after
CRT, so that individual mechanical response to CRT can be
assessed. A moderate correlation was detected between %
change of EF% and that of SDI, and selective dyssynchrony
parameters (Table 2). These results suggest that individual esti-
mation of selective dyssynchrony parameters on time/volume
curves can be useful for accurate and individual assessment
of mechanical CRT response.5.1. Clinical implications
RT3DE can be used to determine the SMMD and to assess
individual LV mechanical dyssynchrony. Guided by RT3DE,
positioning of the RL at the pre-identiﬁed SMMD can lead
162 D.A. Fouad, R.M.S. Eldeento more optimum resynchronization effects (up to 80%)
regardless the method of CRT used.
The use of septal RL can be a new, more reasonable and
economic solution for the subset of patients having septal
SMMD. This is a rather important issue in developing coun-
tries like Egypt.
5.2. Limitations
The small study population, due to limited fund, is the main
limitation of the present study. However, the small number
of patients enabled us to give patients better chance for opti-
mum RL positioning on prospective basis. The absence of a
gold-standard echocardiographic technique to evaluate LV
dyssynchrony parameters capable of predicting response to
CRT up till now is another limitation. Large multicenter stud-
ies are needed for accurate validation of LV dyssynchrony
parameters obtained from RT3DE.
5.3. Recommendations
Every effort should be made to implant the RL at the SMMD
whenever possible in order to achieve a more optimum CRT
response. On the other hand, we can recommend the use of
BFRVP with septal RL positioning in case of septal SMMD.
However, further studies including larger number of patients
are needed to clarify this issue.
6. Conclusions
The use of RT3DE for individual assessment of LV mechani-
cal dyssynchrony and for optimal RL positioning at the pre-
identiﬁed SMMD can provide more optimum CRT regardless
the method of CRT used.
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